arrow
J

Jay-Jiguang Zhu

University of Texas Health Science Center at Houston
H指数:32
被引数:7,184

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular Features of IDH-Wild Type Glioblastoma in Extreme Survival Poles Following Supramaximal and Maximal Resection: A Single-Institution Retrospective Cohort Study

IDH野生型胶质母细胞瘤在极端生存极值下接受超最大化和最大化切除术后的分子特征:一项单机构回顾性队列研究

2026-04-010
PRE
SURVIVAL BENEFIT OF ADDING OSIMERTINIB TO STANDARD SALVAGE TREATMENT REGIMENS FOR RECURRENT GLIOBLASTOMA (GBM) WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ALTERATIONS

在表皮生长因子受体(EGFR)发生改变的情况下,将奥希替尼(Osimertinib)添加到标准挽救治疗方案中治疗复发胶质母细胞瘤(GBM)的生存获益

2025-11-010
PRE
Vaccine immunotherapy by homologous antigenic loading as adjuvant therapy for glioblastoma: Ongoing phase I analysis
2024-04-050
PRE
Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation
2023-03-279
OAAI
BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review
2022-11-014
OA
Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab

替莫唑胺,伊立替康和贝伐单抗联合治疗的胶质母细胞瘤患者器官特异性毒性的死后研究

2022-10-063
PRE